# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001930970 (1,42)

Office of origin: United States of America

Date of International Registration:10 July 2026
Date of designation in the UK: 10 July 2026

International priority date claimed: 14 January 2026 (United States of America) (99594069)

Class 1
  Monoclonal antibodies for scientific purposes; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; nucleic acids for scientific purposes.
Class 42
  Scientific research and development; research and development of antibodies; research and development in the field of biomedicine; research and development of mRNA drugs; research and development in the field of biotechnology.

Cymba X LLC

Representative: DEBORAH L. LIVELY Pierson Ferdinand LLP, 8604 Turtle Creek Blvd. #12274, Dallas TX 75225, UNITED STATES OF AMERICA